Discontinuation report APO-ATORVASTATIN

Last updated on 2018-11-09 History
Report ID 60282
Drug Identification Number 02295296
Brand name APO-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name APOTEX INC
Active Ingredient(s) ATORVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90 BTL
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-11-05
Actual discontinuation date 2018-11-07
Remaining supply date 2018-11-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-11-09 French Compare
v3 2018-11-09 English Compare
v2 2018-09-07 French Compare
v1 2018-09-07 English Compare